Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8: early-phase trial registry
3 of 5 indexed Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8: 5 US clinical trials tracked, 3 recruiting.
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 2 of these trials.
Enrollment posture brief
Registry condition stage-iii-soft-tissue-sarcoma-of-the-trunk-and-extremities-ajcc-v8
OPEN 3 | RECR 60% | LATE 1 | EARLY 4 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 research.
M.D. Anderson Cancer Center accounts for 2 of 5 trials (40%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 enrolment sits around 122 participants.
Median target enrolment is 122 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
National Cancer Institute (NCI)
NCT06422806
Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
M.D. Anderson Cancer Center
NCT04751409
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
National Cancer Institute (NCI)
NCT06498648
Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk
M.D. Anderson Cancer Center
NCT03819985
Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
Alliance for Clinical Trials in Oncology
NCT05694871
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 condition card totals 5 registered trials; most-linked intervention Computed Tomography; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.